SE445560B - Forfarande och reagens for bestemning av biologiskt aktivt heparin i plasma - Google Patents

Forfarande och reagens for bestemning av biologiskt aktivt heparin i plasma

Info

Publication number
SE445560B
SE445560B SE7902555A SE7902555A SE445560B SE 445560 B SE445560 B SE 445560B SE 7902555 A SE7902555 A SE 7902555A SE 7902555 A SE7902555 A SE 7902555A SE 445560 B SE445560 B SE 445560B
Authority
SE
Sweden
Prior art keywords
plasma
mol
heparin
thrombin
factor
Prior art date
Application number
SE7902555A
Other languages
English (en)
Swedish (sv)
Other versions
SE7902555L (sv
Inventor
K Bartl
H Lill
J Ziegenhorn
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of SE7902555L publication Critical patent/SE7902555L/
Publication of SE445560B publication Critical patent/SE445560B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/10Anilides
    • C12Q2337/12Para-Nitroanilides p-NA
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/81Protease inhibitors
    • G01N2333/8107Endopeptidase (E.C. 3.4.21-99) inhibitors
    • G01N2333/811Serine protease (E.C. 3.4.21) inhibitors
    • G01N2333/8114Kunitz type inhibitors
    • G01N2333/8117Bovine/basic pancreatic trypsin inhibitor (BPTI, aprotinin)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433Serine endopeptidases (3.4.21)
    • G01N2333/96441Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96444Factor X (3.4.21.6)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/914Hydrolases (3)
    • G01N2333/948Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/974Thrombin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G01N2400/10Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • G01N2400/38Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence, e.g. gluco- or galactomannans, Konjac gum, Locust bean gum or Guar gum
    • G01N2400/40Glycosaminoglycans, i.e. GAG or mucopolysaccharides, e.g. chondroitin sulfate, dermatan sulfate, hyaluronic acid, heparin, heparan sulfate, and related sulfated polysaccharides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331Preservative, buffer, anticoagulant or diluent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Neurosurgery (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE7902555A 1978-03-23 1979-03-21 Forfarande och reagens for bestemning av biologiskt aktivt heparin i plasma SE445560B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2812943A DE2812943C3 (de) 1978-03-23 1978-03-23 Verfahren und Reagens zur Bestimmung der biologischen Aktivität von Heparin im Plasma

Publications (2)

Publication Number Publication Date
SE7902555L SE7902555L (sv) 1979-09-24
SE445560B true SE445560B (sv) 1986-06-30

Family

ID=6035376

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7902555A SE445560B (sv) 1978-03-23 1979-03-21 Forfarande och reagens for bestemning av biologiskt aktivt heparin i plasma

Country Status (22)

Country Link
US (1) US4234682A (fr)
EP (1) EP0004271A3 (fr)
JP (1) JPS54128796A (fr)
AR (1) AR217503A1 (fr)
AT (1) AT362080B (fr)
AU (1) AU512206B2 (fr)
BE (1) BE875014A (fr)
CA (1) CA1111334A (fr)
CH (1) CH642749A5 (fr)
DD (1) DD141952A5 (fr)
DE (1) DE2812943C3 (fr)
DK (1) DK149475C (fr)
FI (1) FI62859C (fr)
FR (1) FR2420764A1 (fr)
GB (1) GB2017298B (fr)
HU (1) HU176068B (fr)
IE (1) IE48067B1 (fr)
IT (1) IT1112966B (fr)
LU (1) LU81070A1 (fr)
NL (1) NL7902259A (fr)
SE (1) SE445560B (fr)
ZA (1) ZA79622B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903701C2 (de) * 1979-01-31 1980-10-16 Boehringer Mannheim Gmbh, 6800 Mannheim Kontrollreagens für die Bestimmung der Heparinaktivität
US4244865A (en) * 1979-12-03 1981-01-13 Abbott Laboratories α hydroxy tripeptide substrates
DE3005540A1 (de) * 1980-02-14 1981-08-20 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und reagens zur bestimmung der biologischen aktivitaet von heparin im plasma
DE3019612A1 (de) * 1980-05-22 1981-11-26 Boehringer Mannheim Gmbh, 6800 Mannheim Stabilisiertes thrombinpraeparat
JPH0258920B2 (fr) * 1980-10-09 1990-12-11 Boehringer Mannheim Gmbh
US4473639A (en) * 1982-09-15 1984-09-25 Miles Laboratories, Inc. Reagent strip test for antithrombin-III
US4543335A (en) * 1982-12-20 1985-09-24 Miles Laboratories, Inc. Device and method for the quantitative determination of heparin in mammalian blood plasma
US4946775A (en) * 1985-09-05 1990-08-07 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
DE3679763D1 (de) * 1985-09-05 1991-07-18 E Thye Yin Verfahren und zusammensetzungen zur bestimmung von heparin.
US4851336A (en) * 1985-09-05 1989-07-25 Yin E Thye Composition, kit, and method for assaying heparinano a method for making the composition
US4948724A (en) * 1985-09-05 1990-08-14 Yin E Thye Composition, kit and method for assaying heparin and a method for making the composition
US5939325A (en) * 1989-07-20 1999-08-17 Analytical Control Systems, Inc. Stable whole blood coagulation controls
JP3055933B2 (ja) * 1989-07-20 2000-06-26 アナリティカル・コントロール・システムズ・インコーポレーテッド 改良された安定な凝固対照
CA2070813C (fr) * 1990-11-05 1996-10-29 Hendrik Coenraad Hemker Une methode permettant de determiner la concentration d'anticoagulants
US5308755A (en) * 1992-06-08 1994-05-03 Research Corporation Technologies, Inc. Method for measuring heparin
EP1325962A1 (fr) * 2001-12-17 2003-07-09 Gentium S.p.A. Procédé pour la détermination de l'activité biologique de la defibrotide
EP1745145A4 (fr) * 2004-05-11 2008-03-26 Heptest Lab Inc Compositions, kit et procede en une etape permettant de surveiller des composes possedant des activites d'antifacteur xa et/ou d'antifacteur iia
US7219827B2 (en) 2004-11-19 2007-05-22 General Electric Company Braze end isolation layer for generator armature winding bar and method for applying the isolation layer
DE102005038418A1 (de) * 2005-08-12 2007-02-15 Dade Behring Marburg Gmbh Faktor Xa-basierter Heparinassay unter Verwendung einer Heparin-modifizierenden Komponente
ES2694239T3 (es) 2010-11-12 2018-12-19 Gentium S.R.L. Defibrótido para su uso en profilaxis y/o tratamiento de la enfermedad de Injerto contra huésped (GVHD)
EP2484775A1 (fr) 2011-02-07 2012-08-08 Siemens Healthcare Diagnostics Products GmbH Procédé non sensible à l'héparine destiné à la détermination d'inhibiteurs de facteurs de coagulation directs
RU2627177C2 (ru) 2012-06-22 2017-08-03 Джентиум С.Р.Л. Способ определения биологической активности дефибротида, основанный на применении эуглобулина
EP2843416A1 (fr) 2013-09-02 2015-03-04 Siemens Healthcare Diagnostics Products GmbH Matériau de contrôle et de calibrage pour la détermination d'anticoagulants directs
EP3026122A1 (fr) 2014-11-27 2016-06-01 Gentium S.p.A. Procédé à base cellulaire pour déterminer la puissance de défibrotide
EP3348649A1 (fr) 2017-01-16 2018-07-18 Siemens Healthcare Diagnostics Products GmbH Matériel de contrôle universel pour tests d'inhibiteur de facteur de coagulation
EP4703478A1 (fr) 2024-08-27 2026-03-04 Siemens Healthcare Diagnostics Products GmbH Procédés d'exclusion d'inhibiteurs du facteur xia dans des échantillons de patient

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3769617A (en) * 1971-12-09 1973-10-30 Rca Corp Transmission line using a pair of staggered broad metal strips
SE380257B (sv) * 1972-05-02 1975-11-03 Bofors Ab Nya diagnostiskt verksamma substrat med hog specificitet till trombin och andra proteolytiska enzymer av typen peptidyl-peptid-hydrolaser
US4162941A (en) * 1974-12-05 1979-07-31 Ab Kabi Method for determining a proteolytic enzyme
CH587439A5 (fr) * 1974-12-10 1977-04-29 Daimler Benz Ag
CH622286A5 (fr) * 1975-06-23 1981-03-31 Pentapharm Ag
US4061625A (en) * 1975-07-11 1977-12-06 Ab Kabi Novel chromogenic thrombin substrates
SE407405B (sv) * 1975-07-11 1979-03-26 Kabi Ab Nya kromogena trombinsubstrat
DE2601372C3 (de) * 1976-01-15 1980-03-27 Behringwerke Ag, 3550 Marburg Verfahren zur Bestimmung von Antithrombin III
NL7602423A (nl) * 1976-03-08 1977-09-12 Leuven Res & Dev Vzw Bepaling van heparine in bloedplasma.
US4067777A (en) * 1976-05-13 1978-01-10 Innerfield Irving Determination of heparin in the blood

Also Published As

Publication number Publication date
DK149475B (da) 1986-06-23
GB2017298A (en) 1979-10-03
IE790238L (en) 1979-09-23
FI790476A7 (fi) 1979-09-24
FR2420764B1 (fr) 1983-07-29
FI62859B (fi) 1982-11-30
DK57079A (da) 1979-09-24
DD141952A5 (de) 1980-05-28
JPS5726120B2 (fr) 1982-06-02
AR217503A1 (es) 1980-03-31
US4234682A (en) 1980-11-18
DE2812943C3 (de) 1981-05-14
HU176068B (en) 1980-12-28
DE2812943B2 (de) 1980-08-14
GB2017298B (en) 1982-07-07
DE2812943A1 (de) 1979-10-04
BE875014A (fr) 1979-09-24
NL7902259A (nl) 1979-09-25
AU512206B2 (en) 1980-09-25
ZA79622B (en) 1980-03-26
LU81070A1 (de) 1979-06-19
FR2420764A1 (fr) 1979-10-19
FI62859C (fi) 1983-03-10
EP0004271A3 (fr) 1980-04-02
AT362080B (de) 1981-04-27
DK149475C (da) 1986-12-01
EP0004271A2 (fr) 1979-10-03
SE7902555L (sv) 1979-09-24
IE48067B1 (en) 1984-09-19
IT1112966B (it) 1986-01-20
CH642749A5 (de) 1984-04-30
IT7921220A0 (it) 1979-03-22
AU4382579A (en) 1979-09-27
CA1111334A (fr) 1981-10-27
ATA32179A (de) 1980-09-15
JPS54128796A (en) 1979-10-05

Similar Documents

Publication Publication Date Title
SE445560B (sv) Forfarande och reagens for bestemning av biologiskt aktivt heparin i plasma
US20090087870A1 (en) Hematological assay and kit
DK163671B (da) Reagens og fremgangsmaade til fotometrisk bestemmelse af thromboplastintiden, reagensets fremstilling og anvendelse
US4598043A (en) Method for quantitatively assaying blood coagulation factor XII in human plasma
JPS603840B2 (ja) 血漿中のヘパリンの生物学的活性を測定する方法及びこの方法を実施するための試薬
EP0657547B1 (fr) Methode de titrage de l'activite de l'antithrombine iii
US4918001A (en) Method for the determination of protease inhibitors
JPH06504682A (ja) タンパクs発色原アッセイ
CN108398390A (zh) 一种测定丝氨酸蛋白酶抑制剂活性的方法
CN106568765A (zh) 用于抗凝血酶iii活性测定的凝血酶发色底物液、凝血酶水溶液、方法以及试剂盒
EP1774327A2 (fr) Procedes et kits de mesure de complexes adamts13/fxi
DK161205B (da) Enzymatisk fremgangsmaade til bestemmelse af beta-lactamantibiotica indeholdende en beta-lactam-kerne og proeveudstyr til saadan bestemmelse
EP3460070A1 (fr) Détection améliorée d'anticoagulants dans des fluides corporels
Mousli et al. Ammonia production during clot retraction and its use in assay of fibrinoligase.
JPH0734759B2 (ja) 体液中の抗トロンビン▲iii▼を測定する方法及び試薬
EP0902091A2 (fr) Méthode et trousse pour la mesure de la concentration ou de l'activité d'un inhibiteur de protéase
Paulssen et al. An automated amidolytic assay of thrombin generation: An alternative for the prothrombin-time test
JP2006201176A (ja) 安定な発色性試験用試薬および凝固診断試験におけるその使用
EP1779117A1 (fr) Procédés pour mesurer l'activité de adamts13 et une protéine présente dans des plaquettes et dans le plasma
JP3761925B2 (ja) 安定なプラスミン溶液
RU2195673C2 (ru) Способ определения активности антитромбина iii
JP4311796B2 (ja) アンチトロンビンiiiの測定法
Calvert et al. The effect of bile salts on the esterolytic assay of trypsin
Seghatchian The values of synthetic substrates in the improvement of diagnostic tests for haemostatic function
Heidtmann et al. Assay of functional activity of alpha 1-antichymotrypsin in plasma

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7902555-7

Effective date: 19931008

Format of ref document f/p: F